Baxter International, Inc. (BAX)
23.49
-0.15
(-0.63%)
USD |
NYSE |
Oct 02, 16:00
23.50
+0.01
(+0.04%)
Pre-Market: 20:00
Baxter International EPS Diluted (Quarterly) : 0.2432 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2432 |
| March 31, 2026 | -0.0291 |
| December 31, 2025 | -2.160 |
| September 30, 2025 | 0.0175 |
| June 30, 2025 | 0.2179 |
| March 31, 2025 | 0.2451 |
| December 31, 2024 | -1.002 |
| September 30, 2024 | 0.2734 |
| June 30, 2024 | -0.6157 |
| March 31, 2024 | 0.0726 |
| December 31, 2023 | 0.497 |
| September 30, 2023 | -0.7534 |
| June 30, 2023 | -0.2787 |
| March 31, 2023 | 0.0871 |
| December 31, 2022 | 0.357 |
| September 30, 2022 | -5.827 |
| June 30, 2022 | 0.4961 |
| March 31, 2022 | 0.1395 |
| December 31, 2021 | 0.4694 |
| September 30, 2021 | 0.8893 |
| June 30, 2021 | 0.5855 |
| March 31, 2021 | 0.5832 |
| December 31, 2020 | 0.3256 |
| September 30, 2020 | 0.6873 |
| June 30, 2020 | 0.4758 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6434 |
| December 31, 2019 | -0.0454 |
| September 30, 2019 | 0.7096 |
| June 30, 2019 | 0.6031 |
| March 31, 2019 | 0.6552 |
| December 31, 2018 | 0.5669 |
| September 30, 2018 | 0.9487 |
| June 30, 2018 | 0.63 |
| March 31, 2018 | 0.71 |
| December 31, 2017 | -0.1344 |
| September 30, 2017 | 0.4506 |
| June 30, 2017 | 0.48 |
| March 31, 2017 | 0.4936 |
| December 31, 2016 | 0.439 |
| September 30, 2016 | 0.2359 |
| June 30, 2016 | 2.192 |
| March 31, 2016 | 6.092 |
| December 31, 2015 | 0.3677 |
| September 30, 2015 | 0.0018 |
| June 30, 2015 | 0.6047 |
| March 31, 2015 | 0.7847 |
| December 31, 2014 | 1.74 |
| September 30, 2014 | 0.86 |
| June 30, 2014 | 0.95 |
| March 31, 2014 | 1.01 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DexCom, Inc. | 0.6429 |
| Becton, Dickinson & Co. | 1.370 |
| Abbott Laboratories | 0.5324 |
| Boston Scientific Corp. | 0.615 |
| CONMED Corp. | 0.766 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 135.00M |
| Revenue (Quarterly) | 2.96B |
| Total Expenses (Quarterly) | 2.825B |
| Enterprise Value | 18.82B |
| Gross Profit Margin (Quarterly) | 33.55% |
| Profit Margin (Quarterly) | 4.56% |
| Earnings Yield | -8.21% |
| Operating Earnings Yield | 5.33% |
| Normalized Earnings Yield | -1.752 |